SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-071663
Filing Date
2019-12-11
Accepted
2019-12-11 08:27:19
Documents
14
Period of Report
2019-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924972-1_8k.htm   iXBRL 8-K 28848
2 EXHIBIT 99.1 tm1924972d1_ex99-1.htm EX-99.1 6557
6 GRAPHIC tm1924972d1_ex99-1img01.jpg GRAPHIC 9347
  Complete submission text file 0001104659-19-071663.txt   223675

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvln-20191211.xsd EX-101.SCH 3186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvln-20191211_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvln-20191211_pre.xml EX-101.PRE 22710
7 EXTRACTED XBRL INSTANCE DOCUMENT tm1924972-1_8k_htm.xml XML 3519
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17082 | Film No.: 191278998
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences